![](https://investorshub.advfn.com/uicon/434605.png?cb=1493182534)
Wednesday, March 15, 2017 9:08:22 AM
it's head to head with Intercept to be first in the market for NASH.
phase3, pure development stage biotech, cash likely to last until final approval,
potential market it's huge, but company currently has no revenue, no earnings, just cash burn; if approved will be hitting the market in 2019 and the market cap is....
...980Mln euro, 31mln shares !!!
rumor of a potential ascquisition sent the shares from 20 to 35 Yesterday...
more than one here would say it was corretly priced at 10, where it was last october, beacause it has just uncertainties on its future, nothing sure.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM